Table 1. Relationship between S. mutans Abundance and Proteinuria.

From: Association between Oral Streptococcus Mutans Counts and Proteinuria in Patients with Chronic Kidney Disease: A Pilot Study Using Chlorhexidine

Characteristics S. mutans <103 CFU/mL S. mutans ≥103 CFU/mL p-Value
0 month (n = 18) (n = 39)
Age (yr; mean ± SD) 60.8 ± 18.1 69.2 ± 12.7 0.0478
Sex (M/F) 12/6 29/10 0.5563
Height (cm; mean ± SD) 165.1 ± 12.2 163.6 ± 7.9 0.5907
Body weight (kg; mean ± SD) 63.7 ± 17.9 63.9 ± 15.7 0.9628
BMI (kg/m2; mean ± SD) 23.0 ± 4.1 23.7 ± 4.9 0.5871
Systolic blood pressure (mmHg; mean ± SD) 127.7 ± 15.4 136.7 ± 19.2 0.0843
Diastolic blood pressure (mmHg; mean ± SD) 75.0 ± 10.7 76.7 ± 13.8 0.6431
Hemoglobin (g/dL; mean ± SD) 13.0 ± 2.6 11.5 ± 1.8 0.0151
Serum albumin (g/dL; mean ± SD) 4.0 ± 0.5 3.7 ± 0.3 0.032
Serum creatinine (mg/dL; mean ± SD) 2.0 ± 1.4 2.3 ± 1.2 0.3303
eGFR (mL/min/1.73 m2; mean ± SD) 38.1 ± 21.3 29.6 ± 20.8 0.1619
Urinary protein (g/gCr; mean ± SD) 1.0 ± 0.8 1.9 ± 2.1 0.1170
% Urinary protein ≥2+ 33.3 66.7 0.018
Percentage of urinary sediment ≥5 RBC/HPF 0 23.1 0.0263
RAS-I medication rate, % 66.7 59.0 0.5872
6 months later (n = 18) (n = 38)
Number of S. mutans (log) 0.5 ± 0.8 4.4 ± 1.5 <0.0001
eGFR (mL/min/1.73 m2; mean ± SD) 38.9 ± 21.1 29.0 ± 20.6 0.1011
Urinary protein (g/gCr; mean ± SD) 1.0 ± 0.6 2.3 ± 2.2 0.0134
% Urinary protein ≥2+ 38.9 46.8 0.0388
Percentage of urinary sediment ≥5 RBC/HPF 11.1 23.7 0.277
12 months later (n = 18) (n = 33)
Number of S. mutans (log) 0.2 ± 0.7 4.1 ± 1.6 <0.0001
eGFR (mL/min/1.73 m2; mean ± SD) 36.8 ± 21.4 27.5 ± 20.6 0.1251
Urinary protein (g/gCr; mean ± SD) 0.8 ± 0.7 1.7 ± 1.7 0.0162
% Urinary protein ≥2+ 27.8 67.6 0.0048
Percentage of urinary sediment ≥5 RBC/HPF 11.1 16.2 0.6221
Table 2. Relationship between S. mutans ≥103 CFU/mL and % Urinary Protein ≥2+ at Month 0.

From: Association between Oral Streptococcus Mutans Counts and Proteinuria in Patients with Chronic Kidney Disease: A Pilot Study Using Chlorhexidine

Variables Odds ratio (95% confidence interval) p-Value
Age 1.010 (0.955-1.067) 0.7323
Sex 3.949 (0.821-18.994) 0.0865
Systolic blood pressure (mmHg) 1.047 (1.003-1.093) 0.0346
eGFR (mL/min/1.73 m2) 0.985 (0.948-1.024) 0.4519
Hemoglobin (g/dL) 1.246 (0.823-1.885) 0.2982
RAS-I medication 1.852 (0.452-7.578) 0.3915
S. mutans ≥103 CFU/mL 4.679 (1.008-21.732) 0.0489
Table 3. Relationship between the Degree of Decrease in the Number of S. mutans and Proteinuria <0.3 g/gCr after 12 Months.

From: Association between Oral Streptococcus Mutans Counts and Proteinuria in Patients with Chronic Kidney Disease: A Pilot Study Using Chlorhexidine

Variables Odds ratio (95% confidence interval) p-Value
Age 0.934 (0.799-1.091) 0.3873
Sex 1.442 (0.050-42.000) 0.8314
BMI (kg/m2) 0.723 (0.427-1.226) 0.2292
Systolic blood pressure (mmHg) 1.031 (0.877-1.213) 0.7092
eGFR (mL/min/1.73 m2) 1.097 (0.98-1.227) 0.1076
Proteinuria (g/gCr) (month 0) 0.028 (0.001-1.414) 0.0740
RAS-I medication 9.834 (0.082-1179.978) 0.3493
Degree of decrease in the number of S. mutans after 12 months 0.022 (0.001-0.945) 0.0466
Table 4. Relationship between Reaching S. mutans <103 CFU/mL and Achieving Proteinuria <0.3 g/gCr after 12 Months.

From: Association between Oral Streptococcus Mutans Counts and Proteinuria in Patients with Chronic Kidney Disease: A Pilot Study Using Chlorhexidine

Characteristics S. mutans <103 CFU/mL
at month
0 (n = 18)
P-value S. mutans ≥103 CFU/mL
at 12 months
(n = 27)
P-value S. mutans <103 CFU/mL
at 12 months
(n = 6)
Chronic kidney disease subtypes
Rate of IgA nephropathy, % 27.8 0.7555 7.4 0.1334 33.3
Rate of chronic glomerulonephritis, % 16.7 0.9999 18.5 0.9173 16.7
Rate of nephrosclerosis, % 33.3 0.4461 22.2 0.1874 50.0
Rate of diabetic nephropathy, % 22.2 0.3033 48.1 0.0227 0
Month 0
Age (yr; mean ± SD) 60.8 ± 18.1 0.8411 68.1 ± 11.8 0.3721 62.2 ± 14.5
Sex (M/F) 12/6 0.9999 19/8 0.8644 4/2
Number of S. mutans (log) 0.1 ± 0.2 <0.0001 5.2 ± 0.9 0.0014 4.2 ± 0.8
BMI (kg/m2; mean ± SD) 23.0 ± 4.1 0.1952 23.6 ± 4.7 0.2825 25.9 ± 7.0
Systolic blood pressure (mmHg; mean ± SD) 165.1 ± 12.2 0.7015 127.7 ± 15.4 0.2365 136.7 ± 19.2
Diastolic blood pressure (mmHg; mean ± SD) 75.0 ± 10.7 0.9343 77.8 ± 14.0 0.6949 75.5 ± 13.0
Hemoglobin (g/dL; mean ± SD) 13.0 ± 2.6 0.3044 11.8 ± 1.7 0.7991 12.0 ± 1.9
Serum albumin (g/dL; mean ± SD) 4.0 ± 0.5 0.3623 3.7 ± 0.4 0.6964 3.8 ± 0.3
Serum creatinine (mg/dL; mean ± SD) 2.0 ± 1.4 0.9008 2.2 ± 1.1 0.5669 1.9 ± 1.1
eGFR (mL/min/1.73 m2; mean ± SD) 38.1 ± 21.3 0.8802 30.8 ± 22.6 0.5632 36.5 ± 18.9
Urinary protein (g/gCr; mean ± SD) 1.0 ± 0.8 0.6453 2.0 ± 2.4 0.5299 1.5 ± 1.2
Rate of proteinuria <0.3 g/gCr (%) 5.6 0.5572 3.7 0.6824 0
Percentage of urinary sediment ≥5 RBC/HPF 0 0.0017 14.8 0.0185 50.0
RAS-I medication rate, % 66.7 0.4736 55.6 0.2147 83.3
Month 12
Number of S. mutans (log) 0.2 ± 0.7 0.0002 4.6 ± 1.2 <0.0001 2.0 ± 1.0
eGFR (mL/min/1.73 m2; mean ± SD) 36.8 ± 21.4 0.6688 28.6 ± 21.9 0.6898 32.5 ± 17.8
Urinary protein (g/gCr; mean ± SD) 0.8 ± 0.7 0.9268 1.6 ± 1.5 0.1988 0.8 ± 1.0
Rate of proteinuria <0.3 g/gCr (%) 5.6 0.0028 7.4 0.0028 50.0
Percentage of urinary sediment ≥5 RBC/HPF 11.1 0.7525 18.5 0.9129 16.7
PAGE TOP